Related Experiment Video
Updated: May 1, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Factors predicting recurrent endometrial cancer
A N J Huijgens1, H J M M Mertens2
1Resident, MSc, Dept. Gynecology and Obstetrics, Orbis Medical Center, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, the Netherlands.
Identifying prognostic factors for recurrent endometrial cancer, including age, histological type, and progesterone receptor expression, can improve treatment selection and patient survival outcomes.
Area of Science:
- Gynecology
- Oncology
- Pathology
Background:
- Endometrial cancer recurrence presents a significant challenge with poor prognosis.
- Identifying predictive factors is crucial for improving patient outcomes and adjuvant therapy selection.
Purpose of the Study:
- To identify prognostic factors for predicting recurrent endometrial cancer.
- To enhance the selection of adjuvant therapy based on identified prognostic factors.
Main Methods:
- Retrospective analysis of endometrial cancer patient data from 2002-2010.
- Cox regression analysis to identify independent prognostic factors.
- Kaplan-Meier method for survival analysis.
Main Results:
- Age, histological type, and progesterone receptor expression (PR) were identified as independent prognostic factors for recurrence.
- The PORTEC-1 risk profile and PR expression also proved to be independent prognostic factors.
- PR expression and histological type were significantly associated with disease-specific survival after recurrence.
Conclusions:
- Recurrent endometrial cancer has a poor prognosis despite good overall survival rates.
- Several factors, including PR expression and histological type, are associated with recurrence and survival.
- Utilizing these prognostic factors can lead to more precise patient selection for adjuvant therapies, potentially improving treatment efficacy.
More Related Videos
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Disorders of the Female Reproductive System
Non-LTR Retrotransposons